Search results
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 23 hours agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 1 day agoSome of this momentum can be traced to fears of new infectious disease outbreaks, which may...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 5 days agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following...the average session volume of 4,193,642 shares. Specifically ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 1 day agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 4 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Gateway - Quartz
Quartz· 3 hours agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 7 days agoThe transactions, which took place on June 11, 2024, resulted in the sale of Moderna stock worth...
Magnite’s (MGNI) “Buy” Rating Reaffirmed at Benchmark
ETF DAILY NEWS· 2 days agoBenchmark’s target price would suggest a potential upside of 31.10% from the company’s current price. A number of other brokerages have also recently issued ...
Royal Bank of Canada Boosts Citigroup (NYSE:C) Price Target to $66.00
ETF DAILY NEWS· 1 day agoOther analysts have also issued research reports about the company. Oppenheimer reduced their target price on Citigroup from $87.00 to $86.00 and set an “outperform” rating ...